Keywords: پکت لیتکسل استنت الودگی; coronary artery bypass grafting; percutaneous coronary intervention; coronary stenting; left main disease; Bio-ES; Biolimus-eluting stent; BMS; bare metal stent; CABG; coronary artery bypass grafting; CrI; credible interval; DES; drug-eluting stent; EES;
مقالات ISI پکت لیتکسل استنت الودگی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: پکت لیتکسل استنت الودگی; ATP; adenosine triphosphate; BES; biolimus-eluting stents; BMS; bare-metal stent; cGMP; cyclic guanosine monophosphate; DES; drug-eluting stents; DRP 1; dynamin-related protein 1; EES; everolimus eluting stent; eNOS; endothelial NOS; FAD; flavin adenine d
Keywords: پکت لیتکسل استنت الودگی; Small coronary artery disease; Everolimus-eluting stent; Paclitaxel-eluting stent
Keywords: پکت لیتکسل استنت الودگی; DES; drug-eluting stent; ISR; in-stent restenosis; BMS; bare metal stent; SES; sirolimus-eluting stent; PES; paclitaxel-eluting stent; Coronary endarterectomy; Coronary artery bypass; Percutaneous coronary intervention; In-stent restenosis;
Keywords: پکت لیتکسل استنت الودگی; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADVANCE; Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation; ARTS; Arterial Revascularization Therapies Study; BARI; Bypass Angioplasty Revascularization Inte
Keywords: پکت لیتکسل استنت الودگی; Edge vascular response; Sirolimus-eluting stent; Paclitaxel-eluting stent; IVUS;
Keywords: پکت لیتکسل استنت الودگی; ACh; acetylcholine; BES; biolimus-eluting stent; BMS; bare metal stent; DES; drug-eluting stent; ED; endothelial dysfunction; IVUS; intravascular ultrasound; NO; nitric oxide; OCT; optical coherence tomography; PES; paclitaxel-eluting stent; SES; sirolimu
Keywords: پکت لیتکسل استنت الودگی; Drug-eluting stent; ST-elevation myocardial infarction; Zotarolimus-eluting stent; Sirolimus-eluting stent; Paclitaxel-eluting stent;
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial
Keywords: پکت لیتکسل استنت الودگی; Small coronary vessel disease; Drug-eluting balloon; Paclitaxel-eluting stent; Diabetes mellitus;
Comparison of everolimus- and paclitaxel-eluting stents in dialysis patients
Keywords: پکت لیتکسل استنت الودگی; ESRD; end-stage renal disease; MACE; major adverse cardiac event; SES; sirolimus-eluting stent; TLR; target lesion revascularization; PES; paclitaxel-eluting stent; PCI; percutaneous coronary intervention; EES; everolimus-eluting stent; CKD; chronic kidne
Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)
Keywords: پکت لیتکسل استنت الودگی; Everolimus-eluting stent; Paclitaxel-eluting stent; Chronic kidney disease
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revasculariz
Keywords: پکت لیتکسل استنت الودگی; coronary artery disease; drug-eluting stent; everolimus-eluting stent; long-term follow-up; paclitaxel-eluting stent; randomized trial; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s); EES; everolimus-eluting stent(s); MI; myocardial infarctio
Safety and efficacy of everolimus-eluting stents compared with first-generation drug-eluting stents in patients undergoing primary percutaneous coronary intervention
Keywords: پکت لیتکسل استنت الودگی; Everolimus-eluting stent; ST-elevation myocardial infarction; Sirolimus-eluting stent; Paclitaxel-eluting stent;
Clinical Trials and AnalysisComparison of sirolimus- and paclitaxel-eluting stents in patients with moderate renal insufficiency: results from the J-DESsERT trial
Keywords: پکت لیتکسل استنت الودگی; RI; renal insufficiency; DES; drug-eluting stent; BMS; bare-metal stent; ESRD; end-stage renal disease; MACE; major adverse cardiac event; SES; sirolimus-eluting stent; PES; paclitaxel-eluting stent; TLR; target lesion revascularization; J-DESsERT; Japan-
Sirolimus- vs. paclitaxel-eluting stent to coronary intervention in dialysis patients
Keywords: پکت لیتکسل استنت الودگی; Hemodialysis; Percutaneous coronary intervention; Sirolimus-eluting stent; Paclitaxel-eluting stent;
Propensity-matched lesion-based comparison of midterm outcomes of TAXUS Express and TAXUS Liberté stents for de novo native coronary stenosis
Keywords: پکت لیتکسل استنت الودگی; Paclitaxel-eluting stent; Follow-up result; Restenosis;
Zotarolimus- and Paclitaxel-Eluting Stents in an All-Comer Population in China : The RESOLUTE China Randomized Controlled Trial
Keywords: پکت لیتکسل استنت الودگی; all-comer population; China; drug-eluting stent; paclitaxel-eluting stent; randomized controlled trial; Resolute zotarolimus-eluting stent%DS, percent diameter stenosis; CI, confidence interval; DES, drug-eluting stent(s); LLL, late lumen loss; MI, myocar
Polymer-free Sirolimus-eluting Versus Polymer-based Paclitaxel-eluting Stents: An Individual Patient Data Analysis of Randomized Trials
Keywords: پکت لیتکسل استنت الودگی; DES, drug-eluting stents; LLL, late lumen loss; MI, myocardial infarction; PB-PES, polymer-based paclitaxel-eluting stents; PF-SES, polymer-free sirolimus-eluting stents; ST, stent thrombosisLate lumen loss; Paclitaxel-eluting stent; Polymer; Sirolimus-el
The “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent
Keywords: پکت لیتکسل استنت الودگی; coronary artery disease; paclitaxel-eluting stent; zotarolimus-eluting stentARC, Academic Research Consortium; BMS, bare-metal stent(s); CI, confidence interval; DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); DS, diameter stenosis; E-ZES, En
Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses
Keywords: پکت لیتکسل استنت الودگی; In-stent restenosis; Everolimus; Paclitaxel; Drug-eluting stents; Paclitaxel-eluting stent
Clinical outcomes of zotarolimus-eluting stents versus the first generation sirolimus-eluting stents and paclitaxel-eluting stents: A meta-analysis of randomized trials
Keywords: پکت لیتکسل استنت الودگی; Meta-analysis; Randomized controlled trial; Zotarolimus-eluting stent; Sirolimus-Eluting Stents; Paclitaxel-eluting stent;
Clinical Impact of Second-Generation Everolimus-Eluting Stent Compared With First-Generation Drug-Eluting Stents in Diabetes Mellitus Patients : Insights From a Nationwide Coronary Intervention Register
Keywords: پکت لیتکسل استنت الودگی; all-cause mortality; condensed abstract; diabetes mellitus; everolimus-eluting stent; paclitaxel-eluting stent; restenosis; SCAAR; sirolimus-eluting stent; stent thrombosisCI, confidence interval; CTO, chronic total occlusion; DES, drug-eluting stent(s);
Acute interstitial pneumonitis after implantation of paclitaxel-eluting stents: A report of two fatal cases
Keywords: پکت لیتکسل استنت الودگی; AIP; Acute interstitial pneumonitis; PCI; Percutaneous coronary intervention; PES; Paclitaxel-eluting stents; Paclitaxel-eluting stent; Interstitial pneumonitis; Autopsy;
Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials
Keywords: پکت لیتکسل استنت الودگی; Everolimus-eluting stent; Sirolimus-eluting stent; Paclitaxel-eluting stent; Percutaneous coronary intervention; Meta-analysis
Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: Complete 2-year follow-up of a two-center registry
Keywords: پکت لیتکسل استنت الودگی; Percutaneous coronary intervention; Sirolimus-eluting stent; Paclitaxel-eluting stent; Unprotected left main coronary artery stenosis;
Late stent thrombosis after discontinuation of dual anti-platelet therapy in off-label use of paclitaxel-eluting stent visualized by optical coherence tomography—3-vessel OCT study
Keywords: پکت لیتکسل استنت الودگی; Late stent thrombosis; OCT; Off-label use; Paclitaxel-eluting stent; Dual ant-platelet therapy
Long-term clinical outcome with titanium-nitride-oxide-coated stents and paclitaxel-eluting stents for coronary revascularization in an unselected population
Keywords: پکت لیتکسل استنت الودگی; Titanium-nitride-oxide-coated stent; Paclitaxel-eluting stent; Restenosis; Stent thrombosis;
Use of Drug-Eluting Stents in Patients With Coronary Artery Disease and Renal Insufficiency
Keywords: پکت لیتکسل استنت الودگی; ADMA; asymmetric dimethylarginine; BMS; bare-metal stent; CAD; coronary artery disease; CIN; contrast agent-induced nephropathy; DES; drug-eluting stent; DM; diabetes mellitus; MACE; major adverse cardiac event; MI; myocardial infarction; PCI; percutane
Sirolimus- Versus Paclitaxel-Eluting Stents for the Treatment of Coronary Bifurcations : Results From the COBIS (Coronary Bifurcation Stenting) Registry
Keywords: پکت لیتکسل استنت الودگی; angioplasty; bifurcation lesions; paclitaxel-eluting stent; sirolimus-eluting stentDES, drug-eluting stent(s); IQR, interquartile range; IVUS, intravascular ultrasound; MACE, major adverse cardiac events; MI, myocardial infarction; PCI, percutaneous coron
Outcomes After Implantation of the TAXUS Paclitaxel-Eluting Stent in Saphenous Vein Graft Lesions : Results From the ARRIVE (TAXUS Peri-Approval Registry: A Multicenter Safety Surveillance) Program
Keywords: پکت لیتکسل استنت الودگی; coronary artery bypass graft surgery; paclitaxel-eluting stent; percutaneous coronary intervention; saphenous vein graftBMS, bare-metal stent(s); DAPT, dual antiplatelet therapy; DES, drug-eluting stent(s); MI, myocardial infarction; PCI, percutaneous cor
In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center
Keywords: پکت لیتکسل استنت الودگی; Acute ST-elevation myocardial infarction; Paclitaxel-eluting stent; Target lesion revascularization; Stent thrombosis
Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting Stents : An Integrated Intravascular Ultrasound Analysis From the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials
Keywords: پکت لیتکسل استنت الودگی; intravascular ultrasound; in-stent restenosis; paclitaxel-eluting stent; stent expansionBMS, bare-metal stent(s); DES, drug-eluting stent(s); ISR, in-stent restenosis; IVUS, intravascular ultrasound; MLA, minimal lumen area; MSA, minimum stent area; PES,
Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries
Keywords: پکت لیتکسل استنت الودگی; Paclitaxel-eluting stent; Bioerodible; Sol-gel; Polymer;
Endothelium-Dependent Vasomotor Dysfunction in Pig Coronary Arteries With Paclitaxel-Eluting Stents Is Associated With Inflammation and Oxidative Stress
Keywords: پکت لیتکسل استنت الودگی; endothelial function; paclitaxel-eluting stent; inflammation; oxidative stressBMS, bare-metal stent(s); DES, drug-eluting stent(s); EDdR, endothelium-dependent relaxation; EDiR, endothelium-independent relaxation; ET, endothelin; HEPES, N-(2-hydroxyethyl)
The GENESIS (Randomized, Multicenter Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent System in Patients with De Novo Lesions of the Native Coronary Arteries) Trial
Keywords: پکت لیتکسل استنت الودگی; coronary artery disease; paclitaxel-eluting stent; pimecrolimus-eluting stent; restenosisIVUS, intravascular ultrasound; MACE, major adverse cardiac event; MI, myocardial infarction; MLD, minimal luminal diameter; QCA, quantitative coronary angiography; P
A Randomized Comparison of Sirolimus- Versus Paclitaxel-Eluting Stent Implantation in Patients With Diabetes Mellitus
Keywords: پکت لیتکسل استنت الودگی; coronary artery disease; diabetes mellitus; paclitaxel-eluting stent; sirolimus-eluting stentAMI, acute myocardial infarction; BMS, bare-metal stent(s); CI, confidence interval; DES, drug-eluting stent(s); DM, diabetes mellitus; IQR, interquartile range;
Testing prospectively the effectiveness and safety of paclitaxel-eluting stents in over 1000 very high-risk patients: Design, baseline characteristics, procedural data and in-hospital outcomes of the multicenter Taxus in Real-life Usage Evaluation (TRUE)
Keywords: پکت لیتکسل استنت الودگی; Coronary artery disease; Drug-eluting stent; Paclitaxel-eluting stent; Restenosis; Study design
i2 Innovation in Intervention Summit
Keywords: پکت لیتکسل استنت الودگی; ACUITY; Acute Catheterization and Urgent Intervention Triage Strategy Timing trial; BMS; bare-metal stent; GP; glycoprotein; ICE; intracardiac echocardiography; MACE; major adverse cardiac events; MI; myocardial infarction; MIST; Migraine Intervention wit
Comparison of paclitaxel-eluting stent and sirolimus-eluting stent expansion at incremental delivery pressures
Keywords: پکت لیتکسل استنت الودگی; Paclitaxel-eluting stent; Sirolimus-eluting stent; Intravascular ultrasound
Drug-eluting stents for diabetes mellitus
Keywords: پکت لیتکسل استنت الودگی; BMS; bare-metal stent; DES; drug-eluting stents; ISAR-STEREO; Intracoronary Stenting and Angiographic Results-Strut Thickness Effect on Restenosis Outcomes trial; PCI; percutaneous coronary intervention; PES; paclitaxel-eluting stent; PPAR; peroxisome pro
The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population
Keywords: پکت لیتکسل استنت الودگی; BMS; bare-metal stent; CI; confidence interval; CK-MB; creatine kinase-MB; DES; drug-eluting stent; HR; hazard ratio; MACE; major adverse cardiac event; MI; myocardial infarction; PES; paclitaxel-eluting stent; RESEARCH; Rapamycin-Eluting Stent Evaluated
Clinical and Angiographic Outcome After Implantation of Drug-Eluting Stents in Bifurcation Lesions With the Crush Stent Technique
Keywords: پکت لیتکسل استنت الودگی; AMI; acute myocardial infarction; CI; confidence interval; DES; drug-eluting stent; FKB; final kissing balloon after dilation; HR; hazard ratio; MACE; major adverse cardiac events; OR; odds ratio; PES; paclitaxel-eluting stent; SES; sirolimus-eluting sten